Tessara Therapeutics, a pioneering biotech start-up based in Melbourne, has developed a platform which creates 3D human brain models using stem cells. Its RealBrain technology generates reproducible, scalable micro-tissues that mimic the complexity of the human brain. Ready to accelerate neural drug discovery – without using animal models. From working with CSIRO’s Kickstart program, receiving a CRC-P grant with Xylo Bio, and the University of Sydney to develop neuroplastogens to resear...
All content for The MTPConnect Podcast is the property of MTPConnect and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Tessara Therapeutics, a pioneering biotech start-up based in Melbourne, has developed a platform which creates 3D human brain models using stem cells. Its RealBrain technology generates reproducible, scalable micro-tissues that mimic the complexity of the human brain. Ready to accelerate neural drug discovery – without using animal models. From working with CSIRO’s Kickstart program, receiving a CRC-P grant with Xylo Bio, and the University of Sydney to develop neuroplastogens to resear...
This episode is coming to you from MTPConnect’s Development Workshop Series held in Sydney for 52 start-up organisations from around Australia. The 2-day program was a terrific opportunity for companies participating in our Accelerator programs to get ‘investor ready’. Advisory firm Intrinsika’s workshop, ‘Finding Your Intrinsic Value’, focused on how to reframe a company’s value beyond the financials, by identifying and maximising unique assets and pitching this value to investors. In...
The MTPConnect Podcast
Tessara Therapeutics, a pioneering biotech start-up based in Melbourne, has developed a platform which creates 3D human brain models using stem cells. Its RealBrain technology generates reproducible, scalable micro-tissues that mimic the complexity of the human brain. Ready to accelerate neural drug discovery – without using animal models. From working with CSIRO’s Kickstart program, receiving a CRC-P grant with Xylo Bio, and the University of Sydney to develop neuroplastogens to resear...
